APP and Alzheimer disease: The expression of insulin and IGF-1/2 receptors was found to be markedly reduced in AD brains, which is correlated with pathological alterations, including increased glycogen synthase kinase-3 (GSK-3) activity and amyloid precursor protein (APP) mRNA levels [97].